05.26.21 How Takeda Is Expanding Its Real-World Data Through A Global Myeloma Trial
Combining drugs that may have been shelved with established, safe, and approved drugs has the potential to bring safer, effective therapies to patients. Attend this webinar to learn more about key trends, understanding technical challenges, and shortening timelines by smart working in parallel for scale-up and late-phase development. Click here to register.
Featured Editorial
By Dawn Marie Stull, Takeda Oncology
There is more focus than ever before on tailoring treatment plans to the unique needs of patients. One way to ensure that we as an industry are delivering the most value is by examining real-world data (RWD) throughout the drug development process.
05.24.21 Eli Lilly Weighs The Benefits & Challenges Of Head-To-Head Trials
This report provides data on 240 service provider encounters with 18 electronic clinical outcome assessment/electronic patient reported outcomes (eCOA/ePRO) systems. eCOA/ePRO providers: Learn how your company performs against competitors. Discover where performance exceeds expectations so you can differentiate your offerings from competitors. For sponsors/CROs: Compare your company’s outsourcing philosophy to that of the broader industry. Evaluate your provider selection process. Explore new providers and understand how they have performed for industry peers.
Clinical Leader
In this webinar segment, Tero Laulajainen, VP and head of global clinical science and operations for UCB, and Hassan Kadhim, global head of clinical trial business capabilities, clinical innovation, and industry collaborations at Bristol-Myers Squibb, discuss the guidance issued by regulato
MLB 뉴욕양키스 감염사태가 백신 접종자들에게 주는 교훈 donga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from donga.com Daily Mail and Mail on Sunday newspapers.
04.12.21 Best Practices For Implementing Decentralized Clinical Trials
Sponsor
Is clinical development prepared for the paradigm shift caused by COVID-19? The pandemic has forced the industry to reevaluate how to engage with patients and acquire patient data without direct, in-person access. Biopharmaceutical companies, medical device companies, and CROs from around the world were surveyed to explore the impact on clinical trials in this new paradigm and gain insights into their experiences operationalizing trials in a pandemic. Learn more.
Featured Editorial
By Sam Brown, Nell Haslett-Brousse, Ryan Quinn, and John Theodore, Point B
While the experience design related to the patient is paramount to the adoption of decentralized clinical trial technology, the interrelated experience and incentives for all stakeholders must be fully aligned to realize the full benefits of these platforms.
02.15.21 How Ionis Pharmaceuticals Is Advancing Multiple Late-Stage Trials During COVID
YPrime eCOA Platform Isn’t it about time for a globally proven eCOA technology that gives you peace of mind? One that provides a better user experience for patients, sites and sponsors? YPrime’s eCOA platform delivers even the most complex protocol seamlessly. Developed to integrate intelligently with your other technologies, all modalities are available for site- or home-based trials and paired with secure web backup for guaranteed accuracy and confident, informed decision-making.
It’s Time for the Prime eCOA Solution: It’s Time for YPrime.
Featured Editorial
By Ed Miseta, chief editor, Clinical Leader